Quantcast

Latest Tumor markers Stories

2014-08-19 16:29:12

GILBERT, Ariz., Aug. 19, 2014 /PRNewswire/ -- A cutting-edge research study at Banner MD Anderson Cancer Center is testing the safety and effectiveness of a new investigational drug that, when combined with chemotherapy, may make a major difference in treating breast cancer in patients who carry harmful mutations on either the BRCA1 or BRCA2 genes. The Brocade Study will enroll patients with hereditary breast cancer that is metastatic, meaning it has spread to other parts of the...

Gene Increases Risk Of Developing breast Cancer To One In Three By Age 70
2014-08-08 03:08:44

University of Cambridge Breast cancer risks for one of potentially the most important genes associated with breast cancer after the BRCA1/2 genes are today reported in the New England Journal of Medicine. Women with mutations in the PALB2 gene have on average a one in three chance of developing breast cancer by the age of seventy. In a study run through the international PALB2 Interest Group a team of researchers from 17 centers in eight countries led by the University of Cambridge...

2014-06-26 08:27:43

- Trial will measure investigational compound's efficacy and safety in patients with HER2-negative breast cancer, associated with BRCA 1, BRCA 2 mutations NORTH CHICAGO, Ill., June 26, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a Phase III clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), when added to carboplatin and paclitaxel, two chemotherapeutic medicines, in patients with advanced breast...

2014-06-25 23:14:27

AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June 25, 2014 Advances in genetic testing technology have improved detection rates for BRCA1 and BRCA2 mutations in individuals who are at high risk for breast and ovarian cancer, but some mutations are missed with standard genetic testing. During a recent AllMed webinar, Dr. Della Howell, board-certified hematologist-oncologist,...

2014-06-11 08:31:25

LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Diagnostic Testing World Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cancer_diagnostic_testing_world_markets.html Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs...

2014-06-06 08:24:52

Initial clinical experience with 89Zr-labeled anti-PSMA minibody presented LOS ANGELES, June 6, 2014 /PRNewswire/ -- ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting initial clinical data with an anti-PSMA recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer. The presentation of this initial data coincides with the Company's preparation to expand...

2014-05-27 08:27:46

-- High calibre German consulting company appointed to assist CE Mark registration process SYDNEY, May 27, 2014 /PRNewswire/ -- Australian biotechnology company Minomic International Limited will register its MiStat(TM) ELISA prostate cancer test for CE Mark approval in the latter part of 2014. Achieving CE approval will be a key commercial milestone for the company, allowing it to sell and market its early detection diagnostic technology in the 33 member countries within the...

2014-05-16 12:27:55

The Lipo 7 product is a perfect alternative to the HCG injection product for those preferring vitamins, minerals and amino acids over the hcg injections. NEW HAVEN, Conn., May 16, 2014 /PRNewswire-iReach/ -- Lipotropic Injections are weight loss injections made of natural ingredients like vitamins, minerals and amino acids that assist in metabolizing and burning fats stored in the body. These nutrients are typically given in concentrated doses not typically found in just one meal...

2014-04-24 08:34:08

Beckman Coulter's Prostate Health Index (phi) Available Nationwide for Better Prostate Cancer Detection BREA, Calif., April 24, 2014 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non-invasive blood test that is three times more specific in detecting prostate cancer(1) than PSA (prostate-specific antigen). The new test's accuracy decreases the need for many men...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related